Madrigal Pharmaceuticals’ Rezdiffra (resmetirom) has been approved in Europe for the treatment of metabolic ...

George Lopez, Jesse Garcia and Al Madrigal are among the new additions to the one-night-only virtual table read of the 2007 ...

The world-renowned Philippine Madrigal Singers (MADZ) will take centre stage for a live performance at the Thailand Cultural ...

Highlights,Madrigal Pharmaceuticals shows strong share movement in recent weeks,Revenue growth remains uneven across short- ...

Madrigal Pharmaceuticals ( NASDAQ: MDGL) has received conditional marketing approval from the European Commission for ...

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it ...

MDGL wins EU nod for Rezdiffra as the first and only approved MASH therapy. The drug's launch in Europe is expected in the fourth quarter of 2025.

New York Mets (68-60, second in the NL East) vs. Atlanta Braves (58-70, fourth in the NL East) Atlanta; Saturday, 7:15 p.m. EDT PITCHING PROBABLES: Mets: Clay Holmes (10-6, 3.64 ERA, 1.34 WHIP, 105 ...

Madrigal specifically discusses these risks and uncertainties in greater detail in the sections appearing in Part I, Item 1A of its Annual Report on Form 10-K for the year ended December 31, 2024 ...

Rezdiffra is the first and only medication approved for people living with MASH in the European Union Conditional marketing authorization is based on positive results from the pivotal Phase 3 ...

Conshohocken, Pennsylvania Thursday, August 21, 2025, 14:00 Hrs [IST] ...

Madrigal’s MASH treatment Rezdiffra receives EU approvalMASH, formerly known as nonalcoholic steatohepatitis (NASH), is a serious liver condition that can progress to cirrhosis and liver failure ...